In real-world patients with subjective cognitive impairment (SCC) and mild cognitive impairment (MCI), blood biomarkers for Alzheimer’s disease (AD) and neurodegeneration correlate with underlying pathology, but contribute only little to 5-year models for dementia risk prediction.
Related posts:
Argentina: Argentine President Alberto Fernández tests positive for coronavirus two months after rec...
The death toll from the Israeli bombing of Gaza has risen to 15,523 people since the start of the wa...
Masaya Tashiro Announces Permanent Transfer to Avispa Fukuoka
"The Amazing Benefits of Eating Lupine: A Comprehensive Guide"
